Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer

Current Oncology

Volumn 21, Issue 4, 2014, Pages 181-186

  Chan, A ^a   Woods, R ^a   Kennecke, H ^a   Gill, Sharlene ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Adjuvant therapy; Colon cancer; Delay; Stage III

Indexed keywords

EID: 84905687899     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.1963     Document Type: Article

References (14)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
2. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
3. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11:1879-87.
4. O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997;15:246-50.
5. Andre T, Boni C, Mounedji-Boudiaf L, et al. on behalf of the Multicenter International Study of Oxaliplatin/5- Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (mosaic) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
6. Wolmark N, Wieand S, Kuebler PJ, Colangelo L, O'Connell MJ, Yothers G. A phase iii trial comparing fulv to fulv + oxaliplatin in stage ii or iii carcinoma of the colon: survival results of nsabp Protocol C-07 [abstract LBA4005]. J Clin Oncol 2008;26:. [Available online at: http://meeting.ascopubs.org/cgi/content/short/26/15_suppl/LBA4005; cited May 25, 2014]
7. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage iii colon cancer. N Engl J Med 2005;352:2696-704.
8. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage iii colon cancer. Cancer 2006;107:2581-8.
9. Des Guetz G, Nicolas P, Perret GY, Morere JF, Uzzan B. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 2010;46:1049-55.
10. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011;305:2335-42.
11. Lima IS, Yasui Y, Scarfe A, Winget M. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage iii colon cancer in Alberta, Canada. Cancer 2011;117:3833-40.
12. Cyaykowski PM, Gill S, Kennecke HF, Gordon VL, Turner D. Adjuvant chemotherapy for stage iii colon cancer: does timing matter? Dis Colon Rectum 2011;54:1082-9.
13. Ahmed S, Ahmad I, Zhu T, et al. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study. Dis Colon Rectum 2010;53:1432-8.
14. Haller DG, Tabenero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage iii colon cancer. J Clin Oncol 2011;29:1465-71.